Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
EXPLEOSOL.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
25.85
vs NA
Q4.22
+439%
54
vs 10.01
Q1.23
+149%
45.23
vs 18.18
Q2.23
-42%
13.01
vs 22.39
Q3.23
-49%
13.22
vs 25.85
Q4.23
-59%
21.93
vs 54
Q1.24
-66%
15.31
vs 45.23
Q2.24
+18%
15.4
vs 13.01
Q3.24
+73%
22.86
vs 13.22
Q4.24
-42%
12.75
vs 21.93
Sales Growth
YoY
Current
Estimates
Q3.22
+126%
2.2B vs 970.9M
Q4.22
+127%
2.4B vs 1.1B
Q1.23
+349%
5.1B vs 1.1B
Q2.23
+6%
2.3B vs 2.1B
Q3.23
+7%
2.3B vs 2.2B
Q4.23
+4%
2.5B vs 2.4B
Q1.24
-50%
2.6B vs 5.1B
Q2.24
+12%
2.5B vs 2.3B
Q3.24
+11%
2.6B vs 2.3B
Q4.24
+3%
2.6B vs 2.5B
Return on Equity
QoQ
Q1.23
+13%
0.13
vs 0.1
Q2.23
+4%
0.04
vs 0.13
Q3.23
+4%
0.04
vs 0.04
Q4.23
+6%
0.06
vs 0.04
Q1.24
+3%
0.03
vs 0.06
Q2.24
+4%
0.04
vs 0.03
Q3.24
+5%
0.05
vs 0.04
Q4.24
NA
NA
vs 0.05
Institutionnal Ownership
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How EXPLEOSOL.NS compares to sector?